CN Stock MarketDetailed Quotes

300147 Xiangxue Pharmaceutical

Watchlist
  • 6.42
  • -0.17-2.58%
Market Closed Sep 13 15:00 CST
4.25BMarket Cap-9264P/E (TTM)

Xiangxue Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
Assets
Current assets
Money funds
-19.70%102.35M
-17.99%117.27M
-10.32%149.32M
-21.56%130.96M
-40.93%127.45M
-59.93%142.99M
-15.10%166.5M
1.30%166.96M
0.50%215.76M
-25.01%356.83M
Transactional financial assets
----
7,158.71%4M
----
----
----
-99.91%55.11K
-99.81%125.98K
-92.50%231.17K
1,509.86%75.89M
1,213.27%58.61M
Notes receivable and accounts receivable
10.98%862.15M
13.41%832.14M
16.45%793.8M
46.85%803.78M
-31.13%776.82M
-37.00%733.77M
-38.54%681.65M
-51.41%547.36M
2.42%1.13B
2.39%1.16B
-Notes receivable
-66.29%48.7M
-33.32%87.45M
8.81%88.86M
5,546.15%151.28M
1,149.32%144.47M
--131.16M
555.27%81.66M
--2.68M
--11.56M
--0
-Accounts receivable
28.64%813.45M
23.58%744.69M
17.49%704.94M
19.80%652.5M
-43.36%632.35M
-48.26%602.61M
-45.29%599.99M
-51.65%544.68M
1.37%1.12B
2.39%1.16B
Other receivables (including interest and dividends)
7.21%59.55M
-20.76%51.78M
-31.28%52.55M
-23.80%54.21M
22.38%55.55M
-15.14%65.35M
-77.90%76.47M
-31.38%71.14M
-59.74%45.39M
-90.91%77.01M
-Dividend receivable
--22.44M
--22.44M
0.00%22.44M
----
----
----
--22.44M
----
----
----
-Other receivable
--37.11M
----
-44.27%30.11M
----
----
----
--54.03M
----
-46.51%45.39M
----
Advance payment
-26.83%21.78M
-30.12%27.21M
-55.08%24.55M
-54.42%22.65M
8.09%29.77M
-59.42%38.93M
-28.10%54.66M
-18.85%49.69M
-55.41%27.54M
177.08%95.93M
Inventories
-5.75%462.58M
-19.71%407.6M
-11.94%411.3M
18.25%504.96M
-27.25%490.78M
-28.45%507.63M
-38.66%467.07M
-50.43%427.03M
-20.65%674.65M
-20.16%709.49M
Receivable financing
--0
----
-96.79%642.66K
-95.45%2.34M
-88.37%7.9M
-90.06%8.04M
-81.98%20.05M
-23.26%51.43M
-13.34%67.87M
-35.44%80.9M
Assets held for sale
251.06%312.78M
168.80%311.56M
133.79%323.74M
128.40%291.2M
-12.36%89.1M
8.99%115.91M
-30.39%138.48M
-9.48%127.5M
-30.17%101.66M
-19.39%106.35M
Other current assets
-14.54%68.48M
-17.84%72.22M
-22.38%68.45M
-11.26%78.55M
-70.47%80.12M
-64.74%87.9M
-60.16%88.18M
-36.78%88.51M
111.72%271.35M
174.64%249.28M
Total current assets
14.01%1.89B
7.24%1.82B
7.75%1.82B
23.45%1.89B
-36.45%1.66B
-41.34%1.7B
-45.13%1.69B
-42.67%1.53B
-3.32%2.61B
-22.41%2.9B
Non Current assets
Other equity investment
-2.76%86.53M
-2.76%86.53M
-2.76%86.53M
-10.10%88.98M
-10.10%88.98M
-10.10%88.98M
-10.10%88.98M
-67.33%98.98M
-62.36%98.98M
-62.47%98.98M
Other non-current financial assets
-18.50%38.58M
1.97%48.27M
1.89%48.24M
-14.69%45.95M
-13.96%47.33M
-15.39%47.34M
-16.10%47.35M
-49.86%53.86M
-48.81%55.01M
11.55%55.95M
Investment real estate
----
----
----
----
----
----
----
----
11.84%245.3M
11.96%247.13M
Long-term equity investment
-88.97%34.03M
-86.87%44.18M
-86.98%43.71M
-67.52%107.08M
178.97%308.47M
201.41%336.38M
192.43%335.7M
171.80%329.72M
-11.44%110.57M
-13.53%111.6M
Fixed assets
--3.28B
----
-6.43%3.37B
----
----
----
--3.6B
----
100.20%4B
----
Constru in process
--1.13B
----
2.91%1.21B
----
----
----
--1.18B
----
-47.78%2B
----
Productive biological assets
-3.87%648.91K
-3.04%609.25K
-3.24%560.59K
1.41%538K
-17.83%675K
-22.08%628.35K
-27.05%579.35K
-31.77%530.51K
7.32%821.5K
7.03%806.36K
Intangible assets
-7.69%868.69M
-4.67%907.42M
-4.65%919.28M
-4.70%929.27M
-6.92%941.05M
-7.54%951.92M
-6.79%964.09M
-8.20%975.11M
-5.58%1.01B
69.37%1.03B
Development expenditure
8.32%450.44M
8.83%445.5M
8.33%436.49M
7.79%422.59M
0.85%415.85M
0.92%409.34M
1.89%402.93M
-5.60%392.07M
1.79%412.35M
5.90%405.63M
Goodwill
0.00%199.72M
0.00%199.72M
0.00%199.72M
0.00%199.72M
-25.09%199.72M
-25.09%199.72M
-25.09%199.72M
-68.13%199.72M
-57.45%266.6M
-57.45%266.6M
Long deferred expense
-3.73%36.45M
2.80%38.19M
6.86%40.31M
9.38%37.38M
28.62%37.86M
18.03%37.15M
10.76%37.72M
-5.96%34.17M
-20.97%29.43M
-25.32%31.48M
Deferred tax assets
-0.34%28.4M
8.94%28.72M
-14.79%28.42M
74.71%26.57M
58.43%28.5M
36.59%26.37M
72.14%33.35M
-24.00%15.21M
-11.66%17.99M
0.81%19.3M
Usufruct assets
39.86%33.94M
39.31%35.35M
36.55%36.16M
1,313.63%23.39M
529.46%24.27M
458.67%25.38M
399.97%26.48M
-1.32%1.65M
59.53%3.86M
--4.54M
Other non current assets
11.90%38.48M
31.86%38.87M
6.87%33.08M
-56.13%34.1M
-60.70%34.39M
-53.26%29.48M
-55.45%30.95M
-61.42%77.73M
-58.00%87.51M
-64.80%63.07M
Total non current assets
-8.91%6.23B
-7.03%6.42B
-7.09%6.46B
-15.69%6.58B
-17.97%6.84B
-16.56%6.9B
-8.61%6.95B
-12.97%7.8B
-6.44%8.33B
34.66%8.27B
Total assets
-4.44%8.12B
-4.21%8.24B
-4.18%8.28B
-9.27%8.47B
-22.37%8.49B
-22.99%8.6B
-19.15%8.64B
-19.78%9.33B
-5.72%10.94B
13.08%11.17B
Liabilities
Current liabilities
Short term loan
-3.58%1.45B
-24.49%1.49B
-22.22%1.5B
-18.37%1.51B
-39.25%1.51B
-21.52%1.98B
-21.90%1.93B
-11.25%1.85B
2.72%2.48B
4.12%2.52B
Notes payable and accounts payable
13.86%1.17B
9.31%1.1B
9.94%1.09B
40.35%1.05B
7.38%1.03B
-2.59%1.01B
-23.92%988.95M
-27.52%748.71M
6.47%959.01M
13.54%1.04B
-Notes payable
-94.68%570.63K
-95.76%518.22K
-86.17%2.48M
167.95%9.19M
1,686.76%10.73M
13.28%12.21M
85.21%17.95M
-98.54%3.43M
-99.52%600.3K
-92.45%10.78M
-Accounts payable
15.00%1.17B
10.59%1.1B
11.72%1.08B
39.76%1.04B
6.32%1.02B
-2.76%996.23M
-24.74%971M
-6.54%745.28M
23.41%958.41M
33.20%1.02B
Contract liabilities
10.07%138.98M
-21.17%138.3M
-35.24%161.24M
35.17%101.95M
49.43%126.27M
139.15%175.43M
112.11%248.99M
-24.01%75.42M
-9.08%84.5M
-66.35%73.36M
Advance receipts
--0
--0
96.21%1.57M
----
----
----
--798.17K
----
----
----
Salaries payable
-12.86%34M
-7.89%33.59M
29.93%44.54M
27.88%42.48M
12.51%39.02M
26.16%36.47M
-1.86%34.28M
25.48%33.22M
34.66%34.68M
7.04%28.91M
Taxs payable
-0.12%50.29M
93.19%66.66M
110.22%70.63M
121.02%57.11M
97.21%50.35M
29.79%34.5M
5.17%33.6M
78.80%25.84M
41.98%25.53M
7.88%26.59M
Other payable (including interest and dividends)
10.82%1.93B
6.61%1.87B
3.33%1.86B
-28.05%1.8B
-32.33%1.75B
-32.01%1.75B
-2.53%1.8B
-5.76%2.5B
7.29%2.58B
321.71%2.58B
-Interest payable
--41.04M
----
----
----
----
----
----
----
----
----
-Dividend payable
----
----
-4.26%15M
----
----
----
--15.67M
-39.35%15.67M
-39.35%15.67M
----
-Other payable
--1.89B
----
3.40%1.85B
----
----
----
--1.79B
----
7.79%2.56B
----
Hold and for sell liabilities
-5.13%31.33M
-7.97%29.96M
-29.99%26.21M
3.69%35.24M
-9.00%33.02M
-20.92%32.55M
-57.84%37.43M
7.96%33.99M
-3.04%36.29M
44.16%41.17M
Non current liabilities due within one year
133.67%365.04M
335.04%343.34M
330.08%343.95M
-49.44%118.13M
-47.23%156.22M
-76.92%78.92M
-82.25%79.97M
15.39%233.66M
66.85%296.05M
216.13%341.94M
Other current liabilities
-52.51%45.25M
-13.76%77.64M
-18.40%65.68M
963.21%85.83M
978.50%95.27M
904.16%90.02M
426.71%80.49M
-26.06%8.07M
-23.69%8.83M
-62.64%8.97M
Total current liabilities
9.25%5.22B
-0.64%5.15B
-1.37%5.16B
-12.87%4.8B
-26.48%4.78B
-22.05%5.19B
-17.64%5.23B
-10.50%5.51B
6.94%6.5B
52.10%6.65B
Current liabilities
Long term loan
-36.84%492.89M
28.26%547.27M
30.23%556M
59.97%815.39M
43.20%780.44M
-30.77%426.68M
-19.28%426.93M
-19.51%509.71M
-16.04%544.98M
-23.64%616.29M
Long term account payable
--0
----
--0
----
----
----
--0
----
--0
----
Specific account payable
--75.51M
----
-2.73%117.15M
----
----
----
--120.43M
----
62.53%124.13M
----
Estimate liabilities
-53.75%27.43M
-43.89%28.78M
-44.03%27.78M
43.36%64.22M
32.38%59.3M
209.33%51.29M
199.33%49.63M
--44.8M
3.54%44.8M
-58.20%16.58M
Deferred tax liabilities
--9.25M
--9.46M
42.90%9.46M
----
----
----
77.64%6.62M
721.40%5.24M
508.73%5.41M
10,983.45%2.6M
Long term deferred income
0.00%60.42M
-3.63%60.94M
0.12%60.42M
-2.42%59.39M
-8.86%60.41M
13.62%63.23M
-8.07%60.35M
-20.92%60.86M
-14.31%66.28M
-25.52%55.65M
Lease liabilities
46.16%33.81M
44.56%32.29M
40.13%34.92M
1,361.56%12.93M
1,270.10%23.13M
882.14%22.34M
956.45%24.92M
--884.54K
89.74%1.69M
--2.27M
Total non current liabilities
-33.60%699.31M
15.82%802.68M
16.96%805.73M
44.89%1.08B
33.77%1.05B
-13.57%693.07M
1.53%688.88M
-26.68%746.59M
-26.79%787.29M
-34.25%801.9M
Total liabilities
1.52%5.92B
1.30%5.96B
0.77%5.97B
-5.98%5.88B
-19.97%5.83B
-21.14%5.88B
-15.79%5.92B
-12.80%6.26B
1.87%7.29B
33.27%7.45B
Shareholders equity
Paid-in capital
0.00%661.28M
0.00%661.28M
0.00%661.28M
0.00%661.28M
0.00%661.28M
-0.01%661.28M
-0.01%661.28M
-0.01%661.28M
-0.01%661.28M
-0.02%661.36M
Capital reserve funds
0.00%2.15B
0.00%2.15B
0.00%2.15B
0.00%2.15B
0.00%2.15B
-0.01%2.15B
-0.01%2.15B
-0.22%2.15B
-0.13%2.15B
0.32%2.15B
Surplus reserve funds
0.00%105.37M
0.00%105.37M
0.00%105.37M
0.00%105.37M
0.00%105.37M
0.00%105.37M
0.00%105.37M
0.00%105.37M
0.00%105.37M
0.00%105.37M
Retained profit
-68.89%-1.12B
-72.19%-1.02B
-64.99%-987.43M
-180.40%-744.79M
-383.72%-664.71M
-2,684.58%-594.18M
-774.80%-598.47M
-136.03%-265.62M
-117.83%-137.42M
-102.86%-21.34M
Less:Treasury stock
0.00%8.5M
0.00%8.5M
0.00%8.5M
0.00%8.5M
0.00%8.5M
-3.12%8.5M
-3.12%8.5M
-57.73%8.5M
-57.73%8.5M
-57.18%8.77M
Other composite income
122.70%1.79M
117.72%1.7M
132.60%1.69M
-311.36%-7.96M
-389.91%-7.9M
-600.37%-9.58M
-351.09%-5.19M
-23.22%3.77M
-31.43%2.72M
-54.48%1.91M
Shareholders equity without minority interests
-20.03%1.79B
-18.11%1.89B
-16.56%1.92B
-18.53%2.16B
-19.38%2.24B
-20.21%2.31B
-18.89%2.31B
-27.35%2.65B
-24.50%2.78B
-20.60%2.89B
Minority interests
-4.13%403.28M
-5.00%395.97M
-5.98%388.52M
-0.11%427.23M
-51.89%420.65M
-49.46%416.79M
-49.12%413.22M
-47.48%427.69M
13.41%874.37M
28.04%824.71M
Total shareholder equity
-17.51%2.19B
-16.10%2.29B
-14.96%2.31B
-15.97%2.58B
-27.17%2.66B
-26.70%2.72B
-25.61%2.72B
-31.03%3.08B
-17.93%3.65B
-13.29%3.72B
Total liabilityies and equity
-4.44%8.12B
-4.21%8.24B
-4.18%8.28B
-9.27%8.47B
-22.37%8.49B
-22.99%8.6B
-19.15%8.64B
-19.78%9.33B
-5.72%10.94B
13.08%11.17B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
Reservations with explanatory notes
--
--
--
Unqualified opinion
--
--
--
Auditor
--
--
Beijing Dahua International Accounting Firm (Special General Partnership)
--
--
--
Dahua Certified Public Accountants (Special General Partnership)
--
--
--
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022
Assets
Current assets
Money funds -19.70%102.35M-17.99%117.27M-10.32%149.32M-21.56%130.96M-40.93%127.45M-59.93%142.99M-15.10%166.5M1.30%166.96M0.50%215.76M-25.01%356.83M
Transactional financial assets ----7,158.71%4M-------------99.91%55.11K-99.81%125.98K-92.50%231.17K1,509.86%75.89M1,213.27%58.61M
Notes receivable and accounts receivable 10.98%862.15M13.41%832.14M16.45%793.8M46.85%803.78M-31.13%776.82M-37.00%733.77M-38.54%681.65M-51.41%547.36M2.42%1.13B2.39%1.16B
-Notes receivable -66.29%48.7M-33.32%87.45M8.81%88.86M5,546.15%151.28M1,149.32%144.47M--131.16M555.27%81.66M--2.68M--11.56M--0
-Accounts receivable 28.64%813.45M23.58%744.69M17.49%704.94M19.80%652.5M-43.36%632.35M-48.26%602.61M-45.29%599.99M-51.65%544.68M1.37%1.12B2.39%1.16B
Other receivables (including interest and dividends) 7.21%59.55M-20.76%51.78M-31.28%52.55M-23.80%54.21M22.38%55.55M-15.14%65.35M-77.90%76.47M-31.38%71.14M-59.74%45.39M-90.91%77.01M
-Dividend receivable --22.44M--22.44M0.00%22.44M--------------22.44M------------
-Other receivable --37.11M-----44.27%30.11M--------------54.03M-----46.51%45.39M----
Advance payment -26.83%21.78M-30.12%27.21M-55.08%24.55M-54.42%22.65M8.09%29.77M-59.42%38.93M-28.10%54.66M-18.85%49.69M-55.41%27.54M177.08%95.93M
Inventories -5.75%462.58M-19.71%407.6M-11.94%411.3M18.25%504.96M-27.25%490.78M-28.45%507.63M-38.66%467.07M-50.43%427.03M-20.65%674.65M-20.16%709.49M
Receivable financing --0-----96.79%642.66K-95.45%2.34M-88.37%7.9M-90.06%8.04M-81.98%20.05M-23.26%51.43M-13.34%67.87M-35.44%80.9M
Assets held for sale 251.06%312.78M168.80%311.56M133.79%323.74M128.40%291.2M-12.36%89.1M8.99%115.91M-30.39%138.48M-9.48%127.5M-30.17%101.66M-19.39%106.35M
Other current assets -14.54%68.48M-17.84%72.22M-22.38%68.45M-11.26%78.55M-70.47%80.12M-64.74%87.9M-60.16%88.18M-36.78%88.51M111.72%271.35M174.64%249.28M
Total current assets 14.01%1.89B7.24%1.82B7.75%1.82B23.45%1.89B-36.45%1.66B-41.34%1.7B-45.13%1.69B-42.67%1.53B-3.32%2.61B-22.41%2.9B
Non Current assets
Other equity investment -2.76%86.53M-2.76%86.53M-2.76%86.53M-10.10%88.98M-10.10%88.98M-10.10%88.98M-10.10%88.98M-67.33%98.98M-62.36%98.98M-62.47%98.98M
Other non-current financial assets -18.50%38.58M1.97%48.27M1.89%48.24M-14.69%45.95M-13.96%47.33M-15.39%47.34M-16.10%47.35M-49.86%53.86M-48.81%55.01M11.55%55.95M
Investment real estate --------------------------------11.84%245.3M11.96%247.13M
Long-term equity investment -88.97%34.03M-86.87%44.18M-86.98%43.71M-67.52%107.08M178.97%308.47M201.41%336.38M192.43%335.7M171.80%329.72M-11.44%110.57M-13.53%111.6M
Fixed assets --3.28B-----6.43%3.37B--------------3.6B----100.20%4B----
Constru in process --1.13B----2.91%1.21B--------------1.18B-----47.78%2B----
Productive biological assets -3.87%648.91K-3.04%609.25K-3.24%560.59K1.41%538K-17.83%675K-22.08%628.35K-27.05%579.35K-31.77%530.51K7.32%821.5K7.03%806.36K
Intangible assets -7.69%868.69M-4.67%907.42M-4.65%919.28M-4.70%929.27M-6.92%941.05M-7.54%951.92M-6.79%964.09M-8.20%975.11M-5.58%1.01B69.37%1.03B
Development expenditure 8.32%450.44M8.83%445.5M8.33%436.49M7.79%422.59M0.85%415.85M0.92%409.34M1.89%402.93M-5.60%392.07M1.79%412.35M5.90%405.63M
Goodwill 0.00%199.72M0.00%199.72M0.00%199.72M0.00%199.72M-25.09%199.72M-25.09%199.72M-25.09%199.72M-68.13%199.72M-57.45%266.6M-57.45%266.6M
Long deferred expense -3.73%36.45M2.80%38.19M6.86%40.31M9.38%37.38M28.62%37.86M18.03%37.15M10.76%37.72M-5.96%34.17M-20.97%29.43M-25.32%31.48M
Deferred tax assets -0.34%28.4M8.94%28.72M-14.79%28.42M74.71%26.57M58.43%28.5M36.59%26.37M72.14%33.35M-24.00%15.21M-11.66%17.99M0.81%19.3M
Usufruct assets 39.86%33.94M39.31%35.35M36.55%36.16M1,313.63%23.39M529.46%24.27M458.67%25.38M399.97%26.48M-1.32%1.65M59.53%3.86M--4.54M
Other non current assets 11.90%38.48M31.86%38.87M6.87%33.08M-56.13%34.1M-60.70%34.39M-53.26%29.48M-55.45%30.95M-61.42%77.73M-58.00%87.51M-64.80%63.07M
Total non current assets -8.91%6.23B-7.03%6.42B-7.09%6.46B-15.69%6.58B-17.97%6.84B-16.56%6.9B-8.61%6.95B-12.97%7.8B-6.44%8.33B34.66%8.27B
Total assets -4.44%8.12B-4.21%8.24B-4.18%8.28B-9.27%8.47B-22.37%8.49B-22.99%8.6B-19.15%8.64B-19.78%9.33B-5.72%10.94B13.08%11.17B
Liabilities
Current liabilities
Short term loan -3.58%1.45B-24.49%1.49B-22.22%1.5B-18.37%1.51B-39.25%1.51B-21.52%1.98B-21.90%1.93B-11.25%1.85B2.72%2.48B4.12%2.52B
Notes payable and accounts payable 13.86%1.17B9.31%1.1B9.94%1.09B40.35%1.05B7.38%1.03B-2.59%1.01B-23.92%988.95M-27.52%748.71M6.47%959.01M13.54%1.04B
-Notes payable -94.68%570.63K-95.76%518.22K-86.17%2.48M167.95%9.19M1,686.76%10.73M13.28%12.21M85.21%17.95M-98.54%3.43M-99.52%600.3K-92.45%10.78M
-Accounts payable 15.00%1.17B10.59%1.1B11.72%1.08B39.76%1.04B6.32%1.02B-2.76%996.23M-24.74%971M-6.54%745.28M23.41%958.41M33.20%1.02B
Contract liabilities 10.07%138.98M-21.17%138.3M-35.24%161.24M35.17%101.95M49.43%126.27M139.15%175.43M112.11%248.99M-24.01%75.42M-9.08%84.5M-66.35%73.36M
Advance receipts --0--096.21%1.57M--------------798.17K------------
Salaries payable -12.86%34M-7.89%33.59M29.93%44.54M27.88%42.48M12.51%39.02M26.16%36.47M-1.86%34.28M25.48%33.22M34.66%34.68M7.04%28.91M
Taxs payable -0.12%50.29M93.19%66.66M110.22%70.63M121.02%57.11M97.21%50.35M29.79%34.5M5.17%33.6M78.80%25.84M41.98%25.53M7.88%26.59M
Other payable (including interest and dividends) 10.82%1.93B6.61%1.87B3.33%1.86B-28.05%1.8B-32.33%1.75B-32.01%1.75B-2.53%1.8B-5.76%2.5B7.29%2.58B321.71%2.58B
-Interest payable --41.04M------------------------------------
-Dividend payable ---------4.26%15M--------------15.67M-39.35%15.67M-39.35%15.67M----
-Other payable --1.89B----3.40%1.85B--------------1.79B----7.79%2.56B----
Hold and for sell liabilities -5.13%31.33M-7.97%29.96M-29.99%26.21M3.69%35.24M-9.00%33.02M-20.92%32.55M-57.84%37.43M7.96%33.99M-3.04%36.29M44.16%41.17M
Non current liabilities due within one year 133.67%365.04M335.04%343.34M330.08%343.95M-49.44%118.13M-47.23%156.22M-76.92%78.92M-82.25%79.97M15.39%233.66M66.85%296.05M216.13%341.94M
Other current liabilities -52.51%45.25M-13.76%77.64M-18.40%65.68M963.21%85.83M978.50%95.27M904.16%90.02M426.71%80.49M-26.06%8.07M-23.69%8.83M-62.64%8.97M
Total current liabilities 9.25%5.22B-0.64%5.15B-1.37%5.16B-12.87%4.8B-26.48%4.78B-22.05%5.19B-17.64%5.23B-10.50%5.51B6.94%6.5B52.10%6.65B
Current liabilities
Long term loan -36.84%492.89M28.26%547.27M30.23%556M59.97%815.39M43.20%780.44M-30.77%426.68M-19.28%426.93M-19.51%509.71M-16.04%544.98M-23.64%616.29M
Long term account payable --0------0--------------0------0----
Specific account payable --75.51M-----2.73%117.15M--------------120.43M----62.53%124.13M----
Estimate liabilities -53.75%27.43M-43.89%28.78M-44.03%27.78M43.36%64.22M32.38%59.3M209.33%51.29M199.33%49.63M--44.8M3.54%44.8M-58.20%16.58M
Deferred tax liabilities --9.25M--9.46M42.90%9.46M------------77.64%6.62M721.40%5.24M508.73%5.41M10,983.45%2.6M
Long term deferred income 0.00%60.42M-3.63%60.94M0.12%60.42M-2.42%59.39M-8.86%60.41M13.62%63.23M-8.07%60.35M-20.92%60.86M-14.31%66.28M-25.52%55.65M
Lease liabilities 46.16%33.81M44.56%32.29M40.13%34.92M1,361.56%12.93M1,270.10%23.13M882.14%22.34M956.45%24.92M--884.54K89.74%1.69M--2.27M
Total non current liabilities -33.60%699.31M15.82%802.68M16.96%805.73M44.89%1.08B33.77%1.05B-13.57%693.07M1.53%688.88M-26.68%746.59M-26.79%787.29M-34.25%801.9M
Total liabilities 1.52%5.92B1.30%5.96B0.77%5.97B-5.98%5.88B-19.97%5.83B-21.14%5.88B-15.79%5.92B-12.80%6.26B1.87%7.29B33.27%7.45B
Shareholders equity
Paid-in capital 0.00%661.28M0.00%661.28M0.00%661.28M0.00%661.28M0.00%661.28M-0.01%661.28M-0.01%661.28M-0.01%661.28M-0.01%661.28M-0.02%661.36M
Capital reserve funds 0.00%2.15B0.00%2.15B0.00%2.15B0.00%2.15B0.00%2.15B-0.01%2.15B-0.01%2.15B-0.22%2.15B-0.13%2.15B0.32%2.15B
Surplus reserve funds 0.00%105.37M0.00%105.37M0.00%105.37M0.00%105.37M0.00%105.37M0.00%105.37M0.00%105.37M0.00%105.37M0.00%105.37M0.00%105.37M
Retained profit -68.89%-1.12B-72.19%-1.02B-64.99%-987.43M-180.40%-744.79M-383.72%-664.71M-2,684.58%-594.18M-774.80%-598.47M-136.03%-265.62M-117.83%-137.42M-102.86%-21.34M
Less:Treasury stock 0.00%8.5M0.00%8.5M0.00%8.5M0.00%8.5M0.00%8.5M-3.12%8.5M-3.12%8.5M-57.73%8.5M-57.73%8.5M-57.18%8.77M
Other composite income 122.70%1.79M117.72%1.7M132.60%1.69M-311.36%-7.96M-389.91%-7.9M-600.37%-9.58M-351.09%-5.19M-23.22%3.77M-31.43%2.72M-54.48%1.91M
Shareholders equity without minority interests -20.03%1.79B-18.11%1.89B-16.56%1.92B-18.53%2.16B-19.38%2.24B-20.21%2.31B-18.89%2.31B-27.35%2.65B-24.50%2.78B-20.60%2.89B
Minority interests -4.13%403.28M-5.00%395.97M-5.98%388.52M-0.11%427.23M-51.89%420.65M-49.46%416.79M-49.12%413.22M-47.48%427.69M13.41%874.37M28.04%824.71M
Total shareholder equity -17.51%2.19B-16.10%2.29B-14.96%2.31B-15.97%2.58B-27.17%2.66B-26.70%2.72B-25.61%2.72B-31.03%3.08B-17.93%3.65B-13.29%3.72B
Total liabilityies and equity -4.44%8.12B-4.21%8.24B-4.18%8.28B-9.27%8.47B-22.37%8.49B-22.99%8.6B-19.15%8.64B-19.78%9.33B-5.72%10.94B13.08%11.17B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----Reservations with explanatory notes------Unqualified opinion------
Auditor ----Beijing Dahua International Accounting Firm (Special General Partnership)------Dahua Certified Public Accountants (Special General Partnership)------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data